The Gut Microbiome and Cancer Immunotherapy

This webinar will explore how the gut microbiome influences responses to cancer immunotherapy. We will discuss the latest research linking microbial composition in the gut to treatment outcomes for a variety of cancers and immunotherapies and discuss how these insights can be translated to new treatments.

• What bacteria are associated with response in cancer patients.
• The potential mechanisms of microbiome-mediated response.
• Current approaches to manipulate the microbiome, including diet, probiotics, and fecal microbiota transplantation.

By the end, attendees will gain a clear understanding of the microbiome’s role in cancer immunotherapy responses and its potential to improve patient outcomes through personalized interventions.